News
-
Tsosie to be ASU’s first Indigenous human geneticist
Krystal Tsosie, MPH (Diné/Navajo Nation) is an advocate for Indigenous genomic and data sovereignty. She is a co-founder of the first U.S. Indigenous-led biobank, a 501(c)3 nonprofit research institution called the Native BioData Consortium. Her current research at Arizona State University centers on ethical engagement with Indigenous communities to ensure Indigenous… Read MoreNov. 17, 2022
-
Moderna’s COVID-19 vaccine proves save for young children from 6 months to 5 years, says Creech
Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found. Results of the two-part KidCOVE study of nearly 13,000 children conducted last year at 87 sites in… Read MoreNov. 15, 2022
-
Nicholson studies adverse events in hospitalized children from Clostridioides difficile (C. diff) bacterial infections
Clostridioides difficile (C. diff), labeled an urgent threat by federal health officials, is a bacterium that can be associated with severe gastrointestinal events and is frequently hospital-acquired. While the incidence of C. diff infections increased from the 1990s to the early 2000s, studies looking at the rate of infections more… Read MoreNov. 10, 2022
-
Horst takes on new roles in advancing digital health
Sara Horst, MD, MPH, associate professor of Medicine, has been named associate vice chair for Digital Health Operations for the Department of Medicine and assistant chief for Clinical Informatics for the Division of Gastroenterology, Hepatology and Nutrition. The appointments recognize Horst’s expertise in advancing digital health technologies, including telehealth in… Read MoreNov. 2, 2022
-
VUMC recognized as a level-two Age-Friendly Health System for adherence to the highest standards of care for older adults.
Systems-wide updates aid in implementation of the 4Ms, a framework for providing high-quality care for older patients. Vanderbilt University Medical Center was recognized by the Institute for Healthcare Improvement in March 2022 as a level-two Age-Friendly Health System, adhering to the highest standards of care for older adults. Read MoreOct. 31, 2022
-
McKernan investigates gender differences in interstitial cystitis/bladder pain syndrome patients
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition that causes bladder pressure, pain and lower urinary tract symptoms. It affects 3-8 million women and 1-4 million men in the U.S. Lindsey McKernan, PhD, MPH, and colleagues assessed gender differences in IC/BPS using validated patient-reported outcome measures and qualitative analysis… Read MoreOct. 12, 2022
-
Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award
Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA). Nationally known for designing and conducting clinical research and advancing the treatment of patients with severe infections, Self is VUMC Vice President for Clinical Research… Read MoreOct. 10, 2022
-
Buntin discusses incarceration, community resources, and substance use disorders in health policy panel
A panel of experts on opioid use disorder (OUD) discussed the importance of building recovery ecosystems or networks of resources to respond to the opioid epidemic during the recent Department of Health Policy’s Research into Policy & Practice Lecture at Vanderbilt University Medical Center. The panel included Ernie Fletcher, MD,… Read MoreSep. 27, 2022
-
Creech leads VUMC trial for monkeypox vaccine administration strategies
Vanderbilt University Medical Center is seeking about 30 healthy adults of diverse backgrounds to participate in a national clinical trial to evaluate alternative strategies for administering the monkeypox vaccine to increase the number of available doses. “We have a limited supply of the JYNNEOS vaccine, which is authorized for the… Read MoreSep. 15, 2022
-
Gastineau supported by Dr. William R. Long Fund to pursue research in pediatric injury prevention
The legacy left behind by the late William (Bill) Long, MD, goes far beyond his many years as a beloved Nashville pediatrician. He was a quintessential clinician-educator, always helping advance the mission of Vanderbilt’s Department of Pediatrics and Monroe Carell Jr. Children’s Hospital at Vanderbilt. The family of the longtime… Read MoreSep. 14, 2022